FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082749 [Registered on: 19/03/2025] Trial Registered Prospectively
Last Modified On: 18/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Impact of Exercise and Breathing Training on Physical Health and Quality of Life in Frail CKD Patients: A Clinical Trial 
Scientific Title of Study   Effectiveness Of Low to Moderate Intensity Aerobic Exercises Along with Inspiratory Muscle Training on Physical Performance, Kinesiophobia and Quality of Life in CKD Patients With Frailty- Randomized Controlled Trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gauri Mahendra Sorty 
Designation  Masters of Cardiovascular and Respiratory Physiotherapy Student 
Affiliation  Maharashtra Institute Physiotherapy , Latur 
Address  Maharashtra Institute of Department of Cardiovascular and Respiratory Physiotherapy ,OPD-17,Maharashtra Institute Physiotherapy, MIMSR medical campus, Ambajogai Road ,Latur

Latur
MAHARASHTRA
413531
India 
Phone  9021265624  
Fax    
Email  gaurisorty11@gmail.com   
 
Details of Contact Person
Scientific Query
 
Name  Dr Vishvnath Pawadshetty 
Designation  HOD of Cardiovascular and Respiratory Physiotherapy  
Affiliation  Maharashtra Institute Physiotherapy , Latur 
Address  Maharashtra Institute of Department of Cardiovascular and Respiratory Physiotherapy ,OPD-17,Maharashtra Institute Physiotherapy, MIMSR medical campus, Ambajogai Road ,Latur

Latur
MAHARASHTRA
413531
India 
Phone  9422710990  
Fax    
Email  physiovish@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vishvnath Pawadshetty 
Designation  HOD of Cardiovascular and Respiratory Physiotherapy  
Affiliation  Maharashtra Institute Physiotherapy , Latur 
Address  Maharashtra Institute of Department of Cardiovascular and Respiratory Physiotherapy ,OPD-17,Maharashtra Institute Physiotherapy, MIMSR medical campus, Ambajogai Road ,Latur

Latur
MAHARASHTRA
413531
India 
Phone  9422710990  
Fax    
Email  physiovish@gmail.com  
 
Source of Monetary or Material Support  
Maharashtra Institute of Department of Cardiovascular and Respiratory Physiotherapy ,OPD-17,Maharashtra Institute Physiotherapy, MIMSR medical campus, Ambajogai Road ,Latur 
 
Primary Sponsor  
Name  Maharashtra Institute of Physiotherapy,Latur  
Address  Maharashtra Institute of Physiotherapy, MIMSR Medical Campus, Ambajogai Road ,Latur 413531 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gauri Mahendra Sorty  Yeshwantrao Chavan Rural Hospital,Latur  Maharashtra Institute of Department Of Cardiovascular and Respiratory Physiotherapy ,OPD-17,Maharashtra Institute of Physiotherapy, MIMSR medical campus, Ambajogai Road,Latur
Latur
MAHARASHTRA 
09021265624

gaurisorty11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee for Research on Human Subject   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N189||Chronic kidney disease, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1)Aerobic exercise 2)Inspiratory muscle training   1)Aerobic exercises content warm up, conditioning program and cool down exercise 2)Inspiratory muscle training is given by inspiratory muscle trainer device 
Comparator Agent  Aerobic Exercises only   Aerobic exercises content warm up, conditioning program and cool down exercise 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)If the score of frailty phenotype criteria is more than or equal to 3 patient consider as a frail
2)Patients should able complete 6 min walk test
3)Resting SPO2 more than or equal to 90 percent
4)Chronicity of the disease (more than 3 months)
 
 
ExclusionCriteria 
Details  1)Uncontrolled DM
2)BP more than 180/110 mmhg or less than 80/60mmhg
3)Muscle pain and cramp
4)RPE greater than or equal to 15
5)Chest pain
6)Arrhythmias
7)Obstructive lung disease
8)History of thoracic and abdominal surgery in past 6 month
9)Osteoarthritis of knee
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1)Tempa scale for kinesiophobia
2)VO2 max
3)KDQOL-36  
All outcomes will assess at baseline, at 6th week and 12th week  
 
Secondary Outcome  
Outcome  TimePoints 
1)6MWT
2)(J-CHS) criteria for frailty 
1)patient is able to complete 6mwt
2) (J-CHS) criteria score equal or more than 3 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Informed consent will be obtained, and participants (50 individuals aged 18-60) will be selected based on inclusion/exclusion criteria. They will be randomly assigned into two groups: Group A (Intervention) - aerobic exercises with inspiratory muscle training (IMT), and Group B (Control) - aerobic exercises only. Assessments will include physical performance (VO2), kinesiophobia (Tempa scale), and quality of life (KDQOL-36). The exercise protocol will be conducted 3 days per week for 12 weeks, with each session including 5-10 minutes of warm-up, 20-60 minutes of aerobic conditioning, and 5-10 minutes of cool-down. Pre, mid, and post-intervention evaluations will be done for all participants
GROUP A: The Aerobic exercise
Warm up exercises (5-10 min): Stretching of large muscle groups like calf ,hamstrings, quadriceps ,triceps ,biceps, pectoralis major. 
Conditioning programme (20-60 min) :static cycling, stepping activity, walking (3min each) [2 min of passive interval after each session]
Cool down exercise (5-10 min):Stretching combined with Active range of motion exercises of all the peripheral joints.

Exercise prescription will be individualized, with an initial intensity of 40%- 60% of MHR or/and RPE: 11- 13

Exercise duration will be increased by 5 min after every 2 weeks (to maximum of 60 mins)

Inspiratory muscle training: 5 series with 10 reps each series 2 min interval overload adjust weekly; Beginning with 50% of MIP for 1st to 3rd week ,60% of MIP for 4th to 6th week,70% of MIP for 7th to 9th week, 80% of MIP for 10th to 12th week.

GROUP B: The Aerobic exercise
Warm up exercises (5-10 min): Stretching of large muscle groups like calf ,hamstrings, quadriceps ,triceps ,biceps, pectoralis major. 
Conditioning programme (20-60 min) :static cycling, stepping activity, walking (3min each) [2 min of passive interval after each session]
Cool down exercise (5-10 min):Stretching combined with Active range of motion exercises of all the peripheral joints.

Exercise prescription will be individualized, with an initial intensity of 40%- 60% of MHR or/and RPE: 11- 13

Exercise duration will be increased by 5 min after every 2 weeks (to maximum of 60 mins)

 
Close